Join us and our Innovation Partner, CRISPR QC at our virtual booth at #CRISPRWorldDay next week for an opportunity to talk to Dr Francie Barron, VP of our Innovation Partnership Program, meet our Innovation Partner @CRISPRQC, and join our raffle! Synthego events.synthego.com/e/WorldCRISPRD…

Congratulations to Chief Science Officer of Cardea Bio Dr. Kiana Aran for receiving NIH funding to help set quality control standards for CRISPR therapies. We welcome her leadership and look forward to implementing her guidance. tinyurl.com/crisprqc

April 28th is the 1st San Diego Innovation Day - Celebrate at #FIVETENTHIRTY! 1500+ Attendees, 100+ Exhibitors, Class of 2022 Cool Companies, Games, Art, Pad Squad, and More! 🎟️ Learn More & Register connect.org/five-ten-thirt…

Happy to announce the launch of CRISPR QC as a separate business using our CRISPR-chip™ technology for a range of QC services for CRISPR gene editing. A milestone in realizing real-world applications of our BPU™ Platform: fal.cn/3nxlS #CRISPRQC #Cardea #CardeaBio

Thank you Cardea Bio for launching CRISPR QC to bring to market CRISPR quality control services to improve gene editing. With the BPU™ (Biosignal Process Unit) Platform and CRISPR-CHIP™ we look forward to helping organizations.#CRISPR #CRISPRQC #Cardea

👏👏👏 Who’s ready for Connect’s #FiveTenThirty?

Cardea Bio Completes Planned Launch of CRISPR QC pharmaceuticaldaily.com/cardea-bio-com…

Serra Ventures is proud to have led the financing round for the CRISPR QC, a newly created entity based on Cardea (part of Paragraf®) technology. Cardea has been a portfolio company of Serra since 2015. finance.yahoo.com/news/cardea-bi…

Thank you #connect for naming us a 2022 Cool Company. We look forward to attending #FIVETENTHIRTY and sharing our CRISPR quality control solution!

We’re going to be at #FIVETENTHIRTY April 28th 📆 Petco Park ⚾ Connect hosts San Diego's Innovation Day celebration💡 Learn More ➡️ connect.org/five-ten-thirt…

CRISPR QC selected as a SoCal "Cool Company"! Come by our booth at 5-10-30 at Petco Park on the 28th to learn more about how we are building the standard by which CRISPR can deliver on it’s promise. businesswire.com/news/home/2022…

Honored to have Dr. Kiana Aran and Dr. Paul Grint join our board. Their demonstrated leadership is an invaluable asset to our growing team. businesswire.com/news/home/2022…

We're stepping into 2023 strong: we've just closed our seed round and added George Bonaros to our board of directors. Get all the details from the full press release below. businesswire.com/news/home/2023…

Great article from GenomeWeb interviewing our CEO, Ross Bundy! The article goes over our past, present, and future – from the origins of our technology to our vision for the coming year. ow.ly/JIn250MHa3T #CRISPR #crisprcas9 #geneediting #agriculture #therapeutics

Help us congratulate our co-founder, Kiana Aran, on being selected as one of Inc.'s top female founders! This award is truly a testament to the impact our technology, the CRISPR-Chip, is making. businesswire.com/news/home/2023…

Thrilled to have Zack Raborn, our VP of Operations, featured on the GenRAIT podcast! Discover how CRISPR-Cas9 is shaping the future of healthcare and the role of CRISPR QC in this exciting field. Tune in here: ow.ly/LxkZ50NJC9E #CRISPR #GeneEditing #PodcastInterview

We are thrilled to share that our CRISPR-Chip s now being showcased at the German DHMD Museum in Dresden. Seeing our innovative technology displayed alongside Watson and Crick's DNA model is truly an honor and a testament to the power of the CRISPR-Chip. ow.ly/tfw550NOnkR